Osatrovskaia L A, Fomina M M, Bogoslovskaia E P, Potapov S L, Korman D B
Eksp Onkol. 1988;10(6):44-8.
The dimethylnitrosourea action after oral and parenteral administration was comparatively evaluated on the basis of criteria for the antitumour and cytogenetic activity, as well as for the immune (T-cell) reactivity of tumour-bearing and intact animals. A considerable antitumour effect and the induction of the overload chromosomal aberrations in tumour cells with the complete preservation of bone marrow cells were observed during the oral drug application. Dimethyl nitrosourea-induced T-cell depression in murine spleen was transitory and reversible. Thus the oral administration of the drug was shown to be optimal for realization of its therapeutical activity with the least toxic side effect on the host normal hemopoietic and immunocompetent cells.
根据抗肿瘤和细胞遗传学活性标准以及荷瘤动物和正常动物的免疫(T细胞)反应性标准,对口服和肠胃外给药后二甲基亚硝基脲的作用进行了比较评估。口服给药期间观察到了显著的抗肿瘤作用以及肿瘤细胞中过载染色体畸变的诱导,同时骨髓细胞完全保留。二甲基亚硝基脲诱导的小鼠脾脏T细胞抑制是短暂且可逆的。因此,口服该药物被证明是实现其治疗活性的最佳方式,对宿主正常造血和免疫活性细胞的毒性副作用最小。